Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2

NCT03332355 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Stopped Business Reasons

Conditions

Glioblastoma Multiforme
Anaplastic Astrocytoma

Interventions

DRUG: PAC-1 Compound

Sponsor

Vanquish Oncology, Inc.

Collaborators

[object Object]